Zheng et al. [33] demonstrated that breakdown antiviral immunity in COVID-19 patients is mediated by a consistent reduction in CD107a+ NK, IFN-γ+ NK, IL-2+ NK and TNF-α+ NK cell numbers and the mean fluorescence intensity (MFI) of granzyme B+ NK cells. The gene discussed is IL2; the disease is COVID-19.